KRONOS BIO INC (KRON)
US50107A1043 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.67M | -133.20M | -151.08M | -88.44M | -16.12M | |||
| Depreciation Amortization | 2.14M | 2.27M | 1.98M | 840.00K | 360.00K | |||
| Change In Working Capital | 5.88M | 6.18M | -1.62M | 6.46M | 280.00K | |||
| Other non cash items | 26.08M | 33.83M | 32.80M | 43.23M | 400.00K | |||
| OPERATING CASH FLOW | -78.58M | -90.93M | -117.92M | -37.91M | -15.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -679.00K | -580.00K | -4.26M | -9.57M | -2.95M | |||
| Other Investing Activity | 67.05M | -31.65M | 67.98M | -150.67M | -64.63M | |||
| INVESTING CASH FLOW | 66.37M | -32.22M | 63.72M | -160.24M | -67.58M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -10.00K | 151.24M | -30.00K | |||
| Stock Issued/Repurchased | 567.00K | 850.00K | 4.47M | 264.37M | 105.04M | |||
| FINANCING CASH FLOW | 567.00K | 850.00K | 4.46M | 415.61M | 105.01M | |||
| CHANGE IN CASH | -11.65M | -122.30M | -49.74M | 217.46M | 22.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -78.58M | -90.93M | -117.92M | -37.91M | -15.08M | |||
| Capital Expenditure | -679.00K | -580.00K | -4.26M | -9.57M | -2.95M | |||
| FREE CASH FLOW | -79.26M | -91.51M | -122.18M | -47.48M | -18.03M | |||
All data in USD